oral or injectable tirzepatide Flex-Dose 1 mL 10 mg/mL Oral Tirzepatide Drops – BloomMD

Experiencing fatigue on tirzepatide

Enhanced Satiety: Amplifies medication's appetite control

Bruising after semaglutide shots is common but preventable

Novo Nordisk has announced headline results from the STEP UP study, a phase 3b trial in the global STEP programme, which revealed the trial achieved its primary endpoint by demonstrating a statistically significant and superior weight loss at week 72 with semaglutide 7.2mg versus placebo.STEP UP is a 72-week efficacy and safety trial investigating subcutaneous semaglutide 7.2mg compared to semaglutide 2.4mg and placebo, all administered once weekly

Weight loss was divided into three stages at both temperatures: 1) rapid initial weight loss, 2) slower gradual weight loss, and 3) weight maintenance

however, these increases are not expected to be of clinical relevance